Market Tracker

03/23 6:13am ET

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

142.34
Delayed Data
As of Mar 22
 -0.61 / -0.43%
Today’s Change
95.80
Today|||52-Week Range
160.00
+30.55%
Year-to-Date

Today’s Trading

Previous close142.95
Today’s open143.26
Day’s range140.20 - 143.45
Volume808,572
Average volume (3 months)633,239
Market cap$8.5B
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+22.56%
Earnings growth (this year)+9.73%
Earnings growth (next 5 years)+14.90%
Revenue growth (last year)+12.32%
P/E ratio22.2
Price/Sales4.53
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc+2.07+3.61%
SGENSeattle Genetics Inc+1.08+1.74%
TSROTESARO Inc+6.11+4.08%
PRGOPerrigo Company PLC+0.29+0.43%
Data as of 03/22/2017

Financials

Next reporting dateMay 9, 2017
EPS forecast (this quarter)$2.34
Annual revenue (last year)$1.5B
Annual profit (last year)$396.8M
Net profit margin26.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts